Literature DB >> 31472022

Immune-mediated adverse reactions to vaccines.

Cosby A Stone1, Christine R F Rukasin1, Thomas M Beachkofsky2, Elizabeth J Phillips3,4.   

Abstract

Vaccination continues to be the single most important and successful public health intervention, due to its prevention of morbidity and mortality from prevalent infectious diseases. Severe immunologically mediated reactions are rare and less common with the vaccine than the true infection. However, these events can cause public fearfulness and loss of confidence in the safety of vaccination. In this paper, we perform a systematic literature search and narrative review of immune-mediated vaccine adverse events and their known and proposed mechanisms, and outline directions for future research. Improving our knowledge base of severe immunologically mediated vaccine reactions and their management drives better vaccine safety and efficacy outcomes.
© 2019 The British Pharmacological Society.

Entities:  

Keywords:  adverse drug reactions; allergy; drug allergy; hypersensitivity; immunology; vaccines

Mesh:

Substances:

Year:  2019        PMID: 31472022      PMCID: PMC6955412          DOI: 10.1111/bcp.14112

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  162 in total

1.  IgE sensitization to gelatin: the probable role of gelatin-containing diphtheria-tetanus-acellular pertussis (DTaP) vaccines.

Authors:  M Sakaguchi; S Inouye
Journal:  Vaccine       Date:  2000-04-03       Impact factor: 3.641

2.  A case of granuloma annulare in a child following tetanus and diphtheria toxoid vaccination.

Authors:  E B Baskan; S Tunali; S D Kacar; S B Adim; H Saricaoglu
Journal:  J Eur Acad Dermatol Venereol       Date:  2005-09       Impact factor: 6.166

3.  IgE-mediated systemic reactions to gelatin included in the varicella vaccine.

Authors:  M Sakaguchi; T Yamanaka; K Ikeda; Y Sano; H Fujita; T Miura; S Inouye
Journal:  J Allergy Clin Immunol       Date:  1997-02       Impact factor: 10.793

Review 4.  Herpes zoster vaccine live: A 10 year review of post-marketing safety experience.

Authors:  English D Willis; Meredith Woodward; Elizabeth Brown; Zoran Popmihajlov; Patricia Saddier; Paula W Annunziato; Neal A Halsey; Anne A Gershon
Journal:  Vaccine       Date:  2017-11-22       Impact factor: 3.641

5.  BCG vaccination in patients with severe combined immunodeficiency: complications, risks, and vaccination policies.

Authors:  Beatriz E Marciano; Chiung-Yu Huang; Gyan Joshi; Nima Rezaei; Beatriz Costa Carvalho; Zoe Allwood; Aydan Ikinciogullari; Shereen M Reda; Andrew Gennery; Vojtech Thon; Francisco Espinosa-Rosales; Waleed Al-Herz; Oscar Porras; Anna Shcherbina; Anna Szaflarska; Şebnem Kiliç; Jose L Franco; Andrea C Gómez Raccio; Persio Roxo; Isabel Esteves; Nermeen Galal; Anete Sevciovic Grumach; Salem Al-Tamemi; Alisan Yildiran; Julio C Orellana; Masafumi Yamada; Tomohiro Morio; Diana Liberatore; Yoshitoshi Ohtsuka; Yu-Lung Lau; Ryuta Nishikomori; Carlos Torres-Lozano; Juliana T L Mazzucchelli; Maria M S Vilela; Fabiola S Tavares; Luciana Cunha; Jorge A Pinto; Sara E Espinosa-Padilla; Leticia Hernandez-Nieto; Reem A Elfeky; Tadashi Ariga; Heike Toshio; Figen Dogu; Funda Cipe; Renata Formankova; M Enriqueta Nuñez-Nuñez; Liliana Bezrodnik; Jose Gonçalo Marques; María I Pereira; Viviana Listello; Mary A Slatter; Zohreh Nademi; Danuta Kowalczyk; Thomas A Fleisher; Graham Davies; Bénédicte Neven; Sergio D Rosenzweig
Journal:  J Allergy Clin Immunol       Date:  2014-04       Impact factor: 10.793

6.  Update: vaccine side effects, adverse reactions, contraindications, and precautions. Recommendations of the Advisory Committee on Immunization Practices (ACIP)

Authors: 
Journal:  MMWR Recomm Rep       Date:  1996-09-06

7.  Adverse events associated with childhood vaccines other than pertussis and rubella. Summary of a report from the Institute of Medicine.

Authors:  K R Stratton; C J Howe; R B Johnston
Journal:  JAMA       Date:  1994-05-25       Impact factor: 56.272

8.  Severe serum sickness after H1N1 influenza vaccination.

Authors:  Rana S Bonds; Brent C Kelly
Journal:  Am J Med Sci       Date:  2013-05       Impact factor: 2.378

9.  Children who have received no vaccines: who are they and where do they live?

Authors:  Philip J Smith; Susan Y Chu; Lawrence E Barker
Journal:  Pediatrics       Date:  2004-07       Impact factor: 7.124

10.  Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors:  Karen R Broder; Margaret M Cortese; John K Iskander; Katrina Kretsinger; Barbara A Slade; Kristin H Brown; Christina M Mijalski; Tejpratap Tiwari; Emily J Weston; Amanda C Cohn; Pamela U Srivastava; John S Moran; Benjamin Schwartz; Trudy V Murphy
Journal:  MMWR Recomm Rep       Date:  2006-03-24
View more
  44 in total

Review 1.  Immune-mediated adverse reactions to vaccines.

Authors:  Cosby A Stone; Christine R F Rukasin; Thomas M Beachkofsky; Elizabeth J Phillips
Journal:  Br J Clin Pharmacol       Date:  2019-11-05       Impact factor: 4.335

Review 2.  Myocarditis after COVID-19 mRNA vaccination: A systematic review of case reports and case series.

Authors:  Dae Yong Park; Seokyung An; Amandeep Kaur; Saurabh Malhotra; Aviral Vij
Journal:  Clin Cardiol       Date:  2022-06-02       Impact factor: 3.287

3.  COVID-19 vaccine-induced Stevens-Johnson syndrome.

Authors:  S Dash; C S Sirka; S Mishra; P Viswan
Journal:  Clin Exp Dermatol       Date:  2021-08-19       Impact factor: 4.481

4.  Biphasic anaphylaxis after exposure to the first dose of Pfizer-BioNTech COVID-19 mRNA vaccine.

Authors:  Christophe Abi Zeid Daou; Mohammad A Natout; Nadine El Hadi
Journal:  J Med Virol       Date:  2021-06-06       Impact factor: 20.693

Review 5.  Hidden Dangers: Recognizing Excipients as Potential Causes of Drug and Vaccine Hypersensitivity Reactions.

Authors:  Maria Luisa Caballero; Matthew S Krantz; Santiago Quirce; Elizabeth J Phillips; Cosby A Stone
Journal:  J Allergy Clin Immunol Pract       Date:  2021-03-15

Review 6.  The Current Status and Challenges in the Development of Vaccines and Drugs against Severe Acute Respiratory Syndrome-Corona Virus-2 (SARS-CoV-2).

Authors:  Narasimha M Beeraka; SubbaRao V Tulimilli; Medha Karnik; Surya P Sadhu; Rajeswara Rao Pragada; Gjumrakch Aliev; SubbaRao V Madhunapantula
Journal:  Biomed Res Int       Date:  2021-06-01       Impact factor: 3.411

7.  Cutaneous reaction to BNT162b2 mRNA COVID-19 vaccine.

Authors:  Alba López-Valle; Daniel Falkenhain-López; Celia R Arranz
Journal:  Int J Dermatol       Date:  2021-04-14       Impact factor: 2.736

8.  Efficacy and Safety of COVID-19 Vaccines in Phase III Trials: A Meta-Analysis.

Authors:  Haoyue Cheng; Zhicheng Peng; Wenliang Luo; Shuting Si; Minjia Mo; Haibo Zhou; Xing Xin; Hui Liu; Yunxian Yu
Journal:  Vaccines (Basel)       Date:  2021-06-01

9.  Incidence and Characteristics of Delayed Injection Site Reaction to the mRNA-1273 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine (Moderna) in a Cohort of Hospital Employees.

Authors:  Mark A Jacobson; Adam Zakaria; Zaw Maung; Colin Hart; Timothy H McCalmont; Marlys Fassett; Erin Amerson
Journal:  Clin Infect Dis       Date:  2022-03-01       Impact factor: 9.079

10.  Safety of SARS-CoV-2 vaccines: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Musha Chen; Yue Yuan; Yiguo Zhou; Zhaomin Deng; Jin Zhao; Fengling Feng; Huachun Zou; Caijun Sun
Journal:  Infect Dis Poverty       Date:  2021-07-05       Impact factor: 4.520

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.